year in cardiology 2018: heart failure | European Heart Journal | Oxford Academic Skip to
Main Content Advertisement intended for healthcare professionals Oxford Academic Journals …

Dilated cardiomyopathy (DCM) represents one of the most common causes of non-ischemic
heart failure, characterised by ventricular dilation alongside systolic dysfunction. Despite …

Cardiomyopathies are a heterogeneous group of structural, mechanical, and electrical heart
muscle disorders which often correlate with life-threatening arrhythmias and progressive …

Multiple randomized multicentre clinical trials have established the role of the implantable
cardioverter-defibrillator (ICD) as the mainstay in the treatment of ventricular …

The new 2021 guidelines of the European Society of Cardiology (ESC) for the diagnosis and
treatment of acute and chronic heart failure include a new terminology for heart failure (HF) …

Sudden cardiac death (SCD) secondary to arrhythmia remains a risk in those with dilated
cardiomyopathy (DCM), an implantable cardiac defibrillator (ICD) is an effective strategy to …

Background There is evidence that implantable cardioverter‐defibrillator (ICD) for primary
prevention in people with an ischaemic cardiomyopathy improves survival rate. The …

Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …

Sudden cardiac death and arrhythmia-related events in patients with non-ischaemic dilated
cardiomyopathy (NICM) have been significantly reduced over the last couple of decades as …

Data is lacking on the contemporary risk of death and readmission following implantable
cardioverter-defibrillator (ICD) implantation in patients with non-ischemic cardiomyopathies …